Removing fallopian tubes and ovaries during vaginal hysterectomy: energy-sealing device versus standard technique

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized controlled trial at a single center compares the LigaSure Maryland energy-based vessel-sealing device with the conventional clamp‑cut‑suture technique for opportunistic salpingo‑oophorectomy during vaginal hysterectomy for pelvic organ prolapse. Eligible women who are recommended to have salpingo‑oophorectomy at the time of their vaginal hysterectomy are randomly assigned to one of the two surgical approaches. The trial measures procedure duration, intraoperative blood loss, postoperative pain, length of hospital stay, and complication rates, with intraoperative deviations noted as exclusions. Patients with suspected pelvic malignancy or those planned for non‑vaginal approaches such as vNOTES are excluded.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women aged 18 years or older.
* Scheduled to undergo vaginal hysterectomy for pelvic organ prolapse.
* Recommended to undergo opportunistic salpingo-oophorectomy according to standard clinical indications.
* Able and willing to provide written informed consent.

Exclusion Criteria:

* Suspected or known pelvic malignancy.
* Lack of informed consent.
* Planned opportunistic salpingo-oophorectomy using a non-vaginal surgical approach.
* Planned opportunistic salpingo-oophorectomy using a vNOTES (vaginal natural orifice transluminal endoscopic surgery) approach.
* Intraoperative need to deviate from the assigned surgical technique due to anatomical or technical considerations.

Where it's running

• Wolfson Medical Center
  Holon, Israel Recruiting

Study contacts

• Study coordinator: Michael Babin, MD
• Email: mckerko@gmail.com
• Phone: 972538535549

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk predictor for new urinary incontinence after prolapse surgery

  This study tests a model to predict which women might develop new stress urinary incontinence after pelvic organ prolapse repair.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07601282

• Comparing the Manchester procedure versus vaginal hysterectomy for uterine prolapse

  This study tests whether the Manchester procedure or vaginal hysterectomy works better for women with symptomatic uterine prolapse over a two-year follow-up.

  Recruiting at 6 sites Tampere University Hospital · Helsinki and 5 other locations · NCT07566949

• Poly-L-lactic acid injections for vulvovaginal tissue regeneration

  This trial will try injections of poly-L-lactic acid (PLLA) versus placebo to see if they strengthen vaginal tissue and reduce bulge symptoms and sexual problems in women with stage II anterior vaginal wall prolapse (cystocele).

  Recruiting Duke University · Durham, North Carolina · NCT07544667

• Pelvic floor mesh used in laparoscopic sacrocolpopexy to repair pelvic organ prolapse

  This study tests the ProGYNious mesh to see if it safely and effectively repairs pelvic organ prolapse in adults undergoing laparoscopic surgery.

  Recruiting A.M.I. Agency for Medical Innovations GmbH · Wiener Neustadt, Lower Austria and 3 other locations · NCT07497321

• Paracervical block for pain control after vNOTES uterosacral ligament suspension

  This will test whether a paracervical injection of bupivacaine reduces early postoperative pain in women having vNOTES uterosacral ligament suspension for pelvic organ prolapse.

  Recruiting Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Istanbul, Istanbul · NCT07440576

• Postpartum pelvic floor recovery and early rehabilitation after vaginal birth

  This project tests whether early, individualized pelvic floor muscle training starting 2–3 weeks after a vaginal birth helps people with postpartum pelvic floor symptoms recover better than usual care.

  Recruiting at 2 sites Vastra Gotaland Region · Gothenburg and 1 other locations · NCT07430865

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.